Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris

Clinical trial NCT06444399 · COMPLETED

Trial details

NCT number: NCT06444399
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pityriasis Rubra Pilaris

Start date: 2024-07-29
Primary completion: 2025-09-02
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.